These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39008105)

  • 1. Iloperidone (Fanapt) - a new indication for bipolar disorder.
    Med Lett Drugs Ther; 2024 Jul; 66(1707):115-116. PubMed ID: 39008105
    [No Abstract]   [Full Text] [Related]  

  • 2. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
    Citrome L
    Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for bipolar disorder.
    Med Lett Drugs Ther; 2024 Apr; 66(1699):49-54. PubMed ID: 38576143
    [No Abstract]   [Full Text] [Related]  

  • 5. Iloperidone, asenapine and lurasidone: a primer on their current status.
    Tarazi FI; Stahl SM
    Expert Opin Pharmacother; 2012 Sep; 13(13):1911-22. PubMed ID: 22849428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on newer antipsychotic drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Apr; 49(4):13-5. PubMed ID: 21446639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumateperone (Caplyta) for bipolar depression.
    Med Lett Drugs Ther; 2022 Aug; 64(1656):126-128. PubMed ID: 35921078
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumateperone (Caplyta) for schizophrenia.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):113-116. PubMed ID: 32728011
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics: Brexpiprazole, Lurasidone, Asenapine, Cariprazine, and Iloperidone With Olanzapine as a Comparator.
    Greger J; Aladeen T; Lewandowski E; Wojcik R; Westphal E; Rainka M; Capote H
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):5-12. PubMed ID: 33177350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iloperidone for the management of adults with schizophrenia.
    Crabtree BL; Montgomery J
    Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
    Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
    Bobo WV
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone.
    Post L
    Hosp Community Psychiatry; 1994 Nov; 45(11):1147. PubMed ID: 7530683
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs: asenapine, iloperidone, and bepotastine besilate.
    Hussar DA; Abbas CA
    J Am Pharm Assoc (2003); 2010; 50(1):107-10. PubMed ID: 20097650
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the efficacy and safety of iloperidone as a schizophrenia therapy.
    Nair A; Salem A; Asamoah AL; Gosal R; Grossberg GT
    Expert Opin Pharmacother; 2020 Oct; 21(15):1793-1798. PubMed ID: 32735148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.